Glycogen Storage Disease Type II (GSD II) Terminated Phase 4 Trials for Methotrexate (DB00563)

Back to Glycogen Storage Disease Type II (GSD II)

Also known as: Glycogen Storage Disease Type II GSD II / Glycogen Storage Disease Type II (GSD-II)

IndicationStatusPhase
DBCOND0041318 (Glycogen Storage Disease Type II (GSD II))Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00701701Immune Tolerance Induction StudyTreatment